Moderna is now expecting 2025 research and development costs of about $4.1 billion and selling, general and administrative costs of about $1.1 billion. Cost of sales is expected to come to about $1.2 ...

Dexcom stock stock recovered Friday after the diabetes devices maker missed fourth-quarter profit expectations.

DaVita Inc.'s stock was tumbling 13.5% Friday to lead S&P 500 decliners, after Warren Buffett's Berkshire Hathaway Inc. pared its stake in the provider of kidney dialysis.

The persistent rise in US equities is helping promote a view that the relationships of old for stocks and traditional measures for value-oriented investing strategies no longer apply.

Choreo LLC increased its stake in FactSet Research Systems Inc. (NYSE:FDS – Free Report) by 12.0% in the fourth quarter, ...

The report, entitled Unlocking Operational Excellence in Fund Administration through AI, is based on insights from in-depth ...

Shares of FactSet Research Systems Inc. FDS rose 1.14% to $459.39 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 1.04% to 6, ...

AI is still a nascent part of Moody's business, but the early indicators point to success for company. That makes the stock a terrific opportunity to buy hand over fist. Investors with a long-run ...

FactSet’s private markets data strategy, the relationship between risk and performance on the buy side and fixed income track record ...

The agricultural equipment maker is slated to release its fiscal first-quarter earnings and update its fiscal year outlook on ...